Zhejiang Huakang Pharmaceutical Co Ltd (605077) - Total Liabilities

Latest as of June 2025: CN¥4.32 Billion CNY ≈ $632.34 Million USD

Based on the latest financial reports, Zhejiang Huakang Pharmaceutical Co Ltd (605077) has total liabilities worth CN¥4.32 Billion CNY (≈ $632.34 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 605077 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Zhejiang Huakang Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 605077 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Zhejiang Huakang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang Huakang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Lianfa Textile Co Ltd SHE:002394	China	CN¥1.71 Billion
Hwail Pharmaceutical Co.Ltd KQ:061250	Korea	₩5.29 Billion
AB Sagax (publ) ST:SAGA-A	Sweden	Skr45.26 Billion
Sebang Global Battery Co Ltd KO:004490	Korea	₩696.25 Billion
Bouvet OL:BOUV	Norway	Nkr1.30 Billion
MN Holdings Berhad KLSE:0245	Malaysia	RM252.70 Million
Coca-Cola Embonor S.A SN:EMBONOR-B	Chile	CL$622.25 Billion
Stenhus Fastigheter I Norden AB ST:SFAST	Sweden	Skr8.96 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Zhejiang Huakang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Huakang Pharmaceutical Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.57	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Huakang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Zhejiang Huakang Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.74 Billion ≈ $546.80 Million	+21.45%
2023-12-31	CN¥3.08 Billion ≈ $450.21 Million	+146.29%
2022-12-31	CN¥1.25 Billion ≈ $182.80 Million	+119.33%
2021-12-31	CN¥569.56 Million ≈ $83.34 Million	+16.20%
2020-12-31	CN¥490.16 Million ≈ $71.73 Million	+4.47%
2019-12-31	CN¥469.20 Million ≈ $68.66 Million	-22.73%
2018-12-31	CN¥607.22 Million ≈ $88.86 Million	+18.10%
2017-12-31	CN¥514.17 Million ≈ $75.24 Million	-5.83%
2016-12-31	CN¥546.03 Million ≈ $79.90 Million	--

About Zhejiang Huakang Pharmaceutical Co Ltd

SHG:605077 China Chemicals

Market Cap

$474.06 Million

CN¥3.24 Billion CNY

Market Cap Rank

#12500 Global

#3618 in China

Share Price

CN¥10.69

Change (1 day)

-3.95%

52-Week Range

CN¥10.69 - CN¥19.78

All Time High

CN¥42.31